Abstract
摘要
相似文献
1
Azetepa--a new alkylating agent.阿泽替帕——一种新型烷基化剂。
Isr J Med Sci. 1965 Jul;1(4):805-7.
2
[On the effect of a cytostatic of the methylhydrazine group on malignant hemoblastomas].[关于甲基肼类细胞抑制剂对恶性成血细胞肿瘤的作用]
Wien Med Wochenschr. 1966 May 21;116(21):468-71.
3
[Ixoten therapy in malignant lymphomas].[恶性淋巴瘤的依索替康治疗]
Acta Med Austriaca. 1979;6(5):247-9.
4
Chemotherapy of the lymphomas.淋巴瘤的化学疗法。
Med Times. 1970 May;98(5):96-102.
5
"AZETEPA": A NEW ALKYLATING AGENT.“氮杂环丙烷膦酸乙酯”：一种新型烷化剂。
Med J Aust. 1965 Apr 24;1(17):620-3. doi: 10.5694/j.1326-5377.1965.tb72001.x.
6
Study of Leo-1031 (NSC-134087) in lymphocytic lymphoma and chronic lymphocytic leukemia.Leo-1031（NSC-134087）在淋巴细胞性淋巴瘤和慢性淋巴细胞性白血病中的研究。
Cancer Treat Rep. 1976 Mar;60(3):277-9.
7
The management of generalized lymphosarcomatous disease.全身性淋巴肉瘤病的管理
Med J Aust. 1968 Aug 3;2(5):195-201. doi: 10.5694/j.1326-5377.1968.tb82730.x.
8
Clinical evaluation of a new alkylating agent, azetepa, in one hundred and twenty-five cases of malignant tumors.新型烷化剂氮杂环丙基磷酰胺对125例恶性肿瘤的临床评估
Int J Cancer. 1967 Mar 15;2(2):189-93. doi: 10.1002/ijc.2910020213.
9
[Lycurim in the treatment of patients with chronic lymphocytic leukemia (author's transl)].
Przegl Lek. 1980;37(4):429-35.
10
[Treatment of lymphomas with methyl-hydrazine (Ro 4-6467/1, MIH, "Natulanar")].
Hospital (Rio J). 1966 Sep;70(3):651-69.
Zotero 插件